UCL Cancer Institute



First prostate cancer patient scanned using hyperpolarised MRI in Europe

A University College Hospital prostate cancer patient has undergone diagnosis using hyperpolarised Magnetic Resonance Imaging (MRI) as part of a UCL clinical trial. Led by Dr Shonit Punwani, the trial aims to develop more accurate and personalised treatment for cancer.

Publication date:

Existing drugs could benefit patients with bone cancer, genetic study suggests

A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.

Publication date:

New drug trial effective in shrinking cervical cancer tumours

A new drug trialled at the NIHR/Wellcome UCLH Clinical Research Facility (CRF) could help improve outcomes for women with advanced cervical cancer. More than a quarter the participants in trials of the immunotherapy drug Nivolumab experienced significant tumour shrinkage or complete remission. 

Publication date:

FOXFIRE combined analysis study results announced

Analysis from the FOXFIRE studies, led by Professor Ricky Sharma, indicates no benefit in overall survival from adding selective internal radiotherapy (SIRT) to first-line oxaliplatin-based chemotherapy for metastatic colorectal cancer.

Publication date:

Drug improves survival of patients with rare cancer by almost a quarter

Patients who take the chemotherapy drug, capecitabine, after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug, according to the results of a phase III clinical trial presented at the 2017 ASCO Annual Meeting in Chicago.

Publication date: